Elizabeth A. Giuliani

Author

United States Military Academy

Also Known As

E A Giuliani, E Giuliani, E. A. Giuliani, E. GIULIANI, Elizabeth A. Giuliani

Publications

2.2K

Citations

H-Index

Concepts

All Affiliations

United States Military Academy Merck & Co., Inc., Rahway, NJ, USA (United States)

About

Elizabeth A. Giuliani is an author at United States Military Academy specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	1.8K
2	Natural Sciences	5	5	800
3	Biochemistry	5	5	800
4	Cell Biology	4	4	1.5K
5	Cellular Physiology	1	1	146

Elizabeth A. Giuliani

Publications

2.2K

Citations

H-Index

Page 1

	Year	Citations
Selective Inhibition of <i>ras</i> -Dependent Transformation by a Farnesyltransferase Inhibitor Nancy E. Kohl, Scott D. Mosser, S. J. DESOLMS, Science Molecular BiologyChemical BiologyRas ProcessingTumor BiologyMolecular Pharmacology	1993	579
Inhibition of farnesyltransferase induces regression of mammary and salivary carcinomas in ras transgenic mice Nancy E. Kohl, Charles A. Omer, Michael W. Conner, Nature Medicine Farnesyltransferase Induces RegressionTumor BiologyChemoprevention StrategyOncogenic AgentMedicine	1995	538
Protein farnesyltransferase inhibitors block the growth of ras-dependent tumors in nude mice. Nancy E. Kohl, Francine R. Wilson, S D Mosser, Proceedings of the National Academy of Sciences PathologyCancer BiologyTumor BiologyOncologyCancer Cell Biology	1994	286
Farnesyltransferase Inhibition Causes Morphological Reversion of <i>ras</i> -Transformed Cells by a Complex Mechanism That Involves Regulation of the Actin Cytoskeleton George C. Prendergast, Joseph P. Da Vide, S. J. DESOLMS, Molecular and Cellular Biology	1994	194
Farnesyltransferase inhibition causes morphological reversion of ras-transformed cells by a complex mechanism that involves regulation of the actin cytoskeleton. George C. Prendergast, Joseph P. Davide, S. J. DESOLMS, Molecular and Cellular Biology Molecular RegulationFarnesyltransferase InhibitionCell ProliferationCytoskeletonCell Growth	1994	146
L-687,908, a potent hydroxyethylene containing HIV protease inhibitor Joseph P. Vacca, James P. Guare, S. J. DESOLMS, Journal of Medicinal Chemistry Pharmaceutical ScienceAltmetric Attention ScorePharmacotherapyAntiviral DrugPharmaceutical Chemistry	1991	124
Pseudopeptide Inhibitors of Ras Farnesyl-Protein Transferase Samuel Graham, S. J. DESOLMS, Elizabeth A. Giuliani, Journal of Medicinal Chemistry	1994	110
Design and synthesis of HIV protease inhibitors. Variations of the carboxyterminus of the HIV protease inhibitor L-682,679 S. J. DESOLMS, Elizabeth A. Giuliani, James P. Guare, Journal of Medicinal Chemistry	1991	41
NMR studies of novel inhibitors bound to farnesyl‐protein transferase Kenneth S. Koblan, Scott D. Mosser, Charles A. Omer, Protein Science	1995	41
A series of potent HIV-1 protease inhibitors containing a hydroxyethyl secondary amine transition state isostere: synthesis, enzyme inhibition, and antiviral activity Thomas J. Tucker, William C. Lumma, Linda S. Payne, Journal of Medicinal Chemistry Antiviral DrugChemical BiologyPharmaceutical ChemistryMedicinal ChemistryAntiviral Activity	1992	41

Page 1